Esophageal Neoplasm

4

Review clinical trials related to Esophageal Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of Medicine have previously reported our Esophageal ESD experience using the monopolar current knife. Moreover, the research team have previously reported on the clinical efficacy of the bipolar RFA knife during per-oral endoscopic myotomy (POEM) and colonic ESD. The goal of our study is to prospectively evaluate the efficacy, safety and feasibility of Esophageal ESD using a novel Bipolar-Current ESD device.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Baylor College of MedicineUpdated: Mar 25, 2026Locations: 1
Eligibility criteria

Patient is >18 years of age [+4]

Patients with International Normalized Ratio (INR) >1.5 or Platelets <50,000 [+2]

Status: Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.

Participants needed: 8,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: UMC UtrechtUpdated: Mar 5, 2026Locations: 18Duration: 2 Years
Eligibility criteria

Patient is to undergo or has completed imaging or treatment procedures on an MR-... [+2]

MRI exclusion criteria, including [+1]

Status: Recruiting

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

The overall objectives of this BETRNet Research Center (RC) are: 1. to conduct a rigorous, integrated spectrum of transdisciplinary human research in Barrett's esophagus (BE) and esophageal adenocarcinoma (ECA) 2. to increase the biological understanding of key observations made by our clinical researchers; 3. to translate knowledge derived from genetic, epigenetic, and transcriptome research to solving clinical dilemmas in detection, prognosis, prevention, and therapy of BE in order to prevent EAC and improve the outcomes of EAC; 4. to foster a transdisciplinary and translation research culture and to effectively expand and enhance scientific research focused on BE and EAC; 5. to evaluate research and transdisciplinary programs and to continuously improve research, productivity and enhance translational implementation. These objectives build and synergize on existing multi-institutional collaborative networks and the considerable clinical, basic science, and translational expertise available at our institutions, focusing on improving the outcomes of patients with BE and EAC. The overarching organization framework for this RC proposal is 1) to focus laboratory research on understanding the genetic susceptibility, genomic and epigenetic changes that influence the development of BE and EAC; and 2) to then translate laboratorydiscoveries into clinical applications for effective detection, molecular risk stratification, and prevention of progression from BE to EAC.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Case Western Reserve UniversityUpdated: Jul 18, 2025Locations: 10
Eligibility criteria

Barrett's esophagus confirmed by review of pathology and endoscopy report or ade... [+2]

Status: Recruiting

Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study

Cervical and upper thoracic esophageal cancer (ESCA) presents treatment challenges due to limited clinical evidence. This multi-center study (ChC\&UES) explores radical radio(chemo)therapy efficacy and safety

Participants needed: 2,600
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hebei Medical University Fourth HospitalUpdated: Jul 1, 2024Locations: 1
Eligibility criteria

Age 18 and older. [+8]

Receipt of radiation dose below 50Gy. [+6]